| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148811 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148789 Novel diazabicyclic aryl derivatives |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148733 Composition containing total triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148084 Effect of growth hormone and IGF-1 on neural stem cells |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147908 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans. |
| 07/06/2006 | US20060147902 Yeast screens for treatment of human disease |
| 07/06/2006 | US20060147558 Remedies |
| 07/06/2006 | US20060147552 Use of iron for treating attention deficit hyperactivity disorder in children |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147425 Use of enteric glia to promote functional nerve connections |
| 07/06/2006 | US20060147386 System and method for intranasal administration of lorazepam |
| 07/06/2006 | DE112004001520T5 Behandlung neurodegenerativer Erkrankungen Treatment of neurodegenerative diseases |
| 07/06/2006 | DE102004027856A1 Neue Pflanzenextrakte mit neuropotektiven, neuroregenerativen und entzündungshemmenden Eigenschaften New plant extracts with neuropotektiven, neuro-regenerative and anti-inflammatory properties |
| 07/06/2006 | DE102004025726B4 Verwendung eines spezifischen K252a-Derivats zur Verhinderung oder Behandlung der Alzheimerschen Krankheit Using a specific K252a derivative for the prevention or treatment of Alzheimer's disease |
| 07/06/2006 | DE102004014841B4 Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms Use of rotigotine for the treatment and prevention of Parkinson's plus syndrome |
| 07/06/2006 | CA2594676A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2594251A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 07/06/2006 | CA2593862A1 Nanoparticle composition and methods for synthesis thereof |
| 07/06/2006 | CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
| 07/06/2006 | CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2591201A1 5-ht7 receptor antagonists |
| 07/06/2006 | CA2591003A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| 07/06/2006 | CA2590681A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/06/2006 | CA2590666A1 5-ht7 receptor antagonists |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/06/2006 | CA2589063A1 Treatment of parkinson's disease and related disorders using postpartum derived cells |
| 07/06/2006 | CA2586410A1 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
| 07/06/2006 | CA2582663A1 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
| 07/05/2006 | EP1676923A1 Sugar chain-cutting agent |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676844A1 5-HT7 receptor antagonists |
| 07/05/2006 | EP1676842A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/05/2006 | EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments |
| 07/05/2006 | EP1676840A1 5-HT7 Receptor antagonists |
| 07/05/2006 | EP1676578A1 Method of stabilizing diarylvinylene compound |
| 07/05/2006 | EP1675862A1 New 2-substituted, 4-amino-thiazolo 4,5-d pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 07/05/2006 | EP1675859A1 Modulators of serotonin receptors |
| 07/05/2006 | EP1675854A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 07/05/2006 | EP1675853A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675591A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
| 07/05/2006 | EP1675582A1 Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
| 07/05/2006 | EP1675578A2 Use of effectors of glutaminyl and glutamate cyclases |
| 07/05/2006 | EP1675568A1 Buccal, polar and non-polar spray containing zolpidem |
| 07/05/2006 | EP1675567A1 Buccal, polar and non-polar spray containing sumatriptan |
| 07/05/2006 | EP1675566A1 Buccal, polar and non-polar spray containing diazepam |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1377575B1 Antiviral pyrazolopyridine compounds |
| 07/05/2006 | EP1259241B1 The use of scopolamine salts |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1113797A4 Treatment of persistent pain |
| 07/05/2006 | CN1798975A Method of screening drug with the use of 67 KDA laminin receptor and drug obtained thereby |
| 07/05/2006 | CN1798750A Thiadiazine derivatives and use thereof as positive ampa receptor modulators |
| 07/05/2006 | CN1798745A Novel 8-aza-bicyclo not 3.2.1|octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/05/2006 | CN1798744A 3-fluoro-piperidines as NMDA/NR2B antagonists. |
| 07/05/2006 | CN1798558A Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 07/05/2006 | CN1798557A Antidepressants or food and drinks for antidepression |
| 07/05/2006 | CN1798552A Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 07/05/2006 | CN1796370A Compound substitution heterocycle class |
| 07/05/2006 | CN1795908A Medication for treating hypochondria and preparation method |
| 07/05/2006 | CN1795907A Pellet for nourish the brain and benefiting intelligence |
| 07/05/2006 | CN1795889A Medication for treating mental disease |
| 07/05/2006 | CN1795886A Medication composition for trating cretinism |
| 07/05/2006 | CN1795863A Preparing derivative of tetradotoxin and application for giving up drug habits and easing pain |
| 07/05/2006 | CN1795857A Composition for covering flavor and preparation of containing the composition |
| 07/05/2006 | CN1795855A Medication for treating senilism dementia and preparing technique |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262301C Medicine for drug rehabilitation |
| 07/05/2006 | CN1262280C Medicine and health-care product formed from ganglioside and ginkgo leaf extract and their application |
| 07/05/2006 | CN1262277C Injection of low molecular weight chondroitin sulfate and its preparation method |
| 07/05/2006 | CN1262272C Carbamate compounds for use in preventing or treating movement disorders |
| 07/05/2006 | CN1262271C Carbamate compounds for use in preventing or treating psychotic disorders |